Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan;13(1):97-104.
doi: 10.1097/MCO.0b013e328332f99d.

Regulation of nitric oxide production in health and disease

Affiliations
Review

Regulation of nitric oxide production in health and disease

Yvette C Luiking et al. Curr Opin Clin Nutr Metab Care. 2010 Jan.

Abstract

Purpose of review: The purpose of this review is to highlight recent publications examining nitric oxide production in health and disease and its association with clinical nutrition and alterations in metabolism.

Recent findings: The role of the cofactor tetrahydrobiopterin in nitric oxide production and its relation with arginine availability is indicated as an important explanation for the arginine paradox. This offers potential for nitric oxide regulation by dietary factors such as arginine or its precursors and vitamin C. Because diets with a high saturated fat content induce high plasma fatty acid levels, endothelial nitric oxide production is often impaired due to a reduction in nitric oxide synthase 3 phosphorylation. Increasing the arginine availability by arginine therapy or arginase inhibition was, therefore, proposed as a potential therapy to treat hypertension. Recent studies in septic patients and transgenic mice models found that inadequate de-novo arginine production from citrulline reduces nitric oxide production. Citrulline supplementation may, therefore, be a novel therapeutic approach in conditions of arginine deficiency.

Summary: Both lack and excess of nitric oxide production in diseases can have various important implications in which dietary factors can play a modulating role. Future research is needed to expand our understanding of the regulation and adequate measurement of nitric oxide production at the organ level and by the different nitric oxide synthase isoforms, also in relation to clinical nutrition.

PubMed Disclaimer

Figures

Figure 1
Figure 1. NO synthesis pathway
Schematic overview of the NO synthesis pathway, involving both enzymatic (via NOS; major pathway) and non-enzymatic pathways. L-arginine is converted to NO and citrulline in the presence of NADPH and oxygen. The NOS pathways depend on essential cofactors (BH4, FAD, FMN and heme) for their activity; NOS1 and NO3 are also Ca2+ dependent. De novo arginine production from citrulline involves the enzymes ASS and ASL. Potential factors that can be modified by dietary intake are indicated by a gray background.

References

    1. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147 1:S193–201. - PMC - PubMed
    1. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–37. - PubMed
    1. Wu G, Morris SM., Jr Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1–17. - PMC - PubMed
    1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–12. - PubMed
    1. Chen K, Pittman RN, Popel AS. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal. 2008;10:1185–98. - PMC - PubMed

Publication types

MeSH terms